Evidence map›Paper›PMID 16791278›Full record

ArticleGenes and immunity2006

Conserved extended haplotypes of the major histocompatibility complex: further characterization.

M T Dorak, W Shao, H K G Machulla, E S Lobashevsky, J Tang, M H Park, R A Kaslow

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Genes and immunity, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 76 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Analysis of HLA Alleles in Different Cohorts of Patients Infected byInternational journal of molecular sciences · 2024
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Sequences of 95 humanGenome research · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

M T DorakDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA. dorak@openlink.org
W Shao
H K G Machulla
E S Lobashevsky
J Tang
M H Park
R A Kaslow
University of Alabama at Birmingham · USMartin Luther University Halle-Wittenberg · DESeoul National University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the complete sequencing of a human major histocompatibility complex (MHC) haplotype, interest in non-human leucocyte antigen (HLA) genes encoded in the MHC has been growing. Non-HLA genes, which outnumber the HLA genes, may contribute to or account for HLA and disease associations. Most information on non-HLA genes has been obtained in separate studies of individual loci. To comprehensively address polymorphisms of relevant non-HLA genes in 'conserved extended haplotypes' (CEH), we investigated 101 International Histocompatibility Workshop reference cell lines and nine additional anonymous samples representing all 37 unambiguously characterized CEHs at MICA, NFKBIL1, LTA, NCR3, AIF1, HSPA1A, HSPA1B, BF, NOTCH4 and a single nucleotide polymorphism (SNP) at HLA-DQA1 as well as MICA, NOTCH4, HSPA1B and all five tumour necrosis factor short tandem repeat (STR) polymorphisms. This work (1) provides an extensive catalogue of MHC polymorphisms in all CEHs, (2) unravels interrelationships between HLA and non-HLA haplotypical lineages, (3) resolves reported typing ambiguities and (4) describes haplospecific markers for a number of CEHs. Analysis also identified a DQA1 SNP and segments containing MHC class III polymorphisms that corresponded with class II (DRB3 and DRB4) lineages. These results portray the MHC where lineages containing non-HLA and HLA variants in linkage disequilibrium may operate in concert and can guide more thorough design and interpretation of HLA-disease relationships.

Indexed as

HaplotypesPolymorphism, Genetic3' Untranslated RegionsAdaptor Proteins, Signal TransducingCalcium-Binding ProteinsCell LineDNA-Binding ProteinsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-B AntigensHLA-DQ AntigensHSP70 Heat-Shock ProteinsHumansLymphotoxin-alphaMajor Histocompatibility ComplexMicrofilament Proteins3' Untranslated RegionsAdaptor Proteins, Signal TransducingAIF1 protein, humanCalcium-Binding ProteinsDNA-Binding ProteinsHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-B67 antigenHLA-B AntigensHLA-DQ AntigensHSP70 Heat-Shock ProteinsHSPA1A protein, humanLymphotoxin-alphaMHC class I-related chain AMicrofilament ProteinsNatural Cytotoxicity Triggering Receptor 3NCR3 protein, humanNFKBIL1 protein, humanNOTCH4 protein, humanProto-Oncogene ProteinsReceptor, Notch4Receptors, ImmunologicReceptors, NotchTNF protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID16791278
OpenAlexW2084028178

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.